← Celsius overview

Celsius vs Monster Beverage: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Celsius Holdings Inc (CELH)

Q3 2026
▼3▲1

Celsius hit by weak results, probes, and activist pressure

  • Weak Q2 results and margin collapse Celsius reported Q2 revenue of $817.9M, missing forecasts, with net income down 45% and operating margin falling to 9.2%. This sharp deterioration in profitability spooked investors and weighed heavily on the stock.

    Directly explains the negative price impact from disappointing financial performance.

  • Regulatory and legal investigations A Texas Attorney General probe into marketing to children and a securities fraud investigation added legal uncertainty. These probes raise the risk of fines, penalties, and reputational damage, pressuring the shares.

    Highlights new legal and regulatory overhangs that emerged during the quarter.

  • Activist pressure and analyst downgrades Activist investor Russ Savage pushed to oust CEO John Fieldly, while Needham, UBS, Roth, and Deutsche Bank cut targets or downgraded the stock. This combination of internal turmoil and negative analyst sentiment eroded investor confidence.

    Shows how governance concerns and reduced analyst optimism contributed to the stock's decline.

  • Takeover interest and insider buying PepsiCo, an 11% stakeholder, and private equity showed takeover interest, potentially delivering a bid premium. Lead Director Hal Kravitz bought 12,000 shares at a premium, signaling insider confidence that the beaten-down stock is undervalued.

    Provides the main positive counterweight, suggesting potential upside from a buyout or insider conviction.

August 2026
▼3▲1

Celsius Q2 Miss and Weak Brand Momentum Drive 2026 Decline

  • Q2 Revenue Miss and Margin Collapse Celsius reported Q2 revenue of $817.9 million, missing estimates by 6.2%, with adjusted EPS of $0.36 versus $0.42 expected. Operating margin fell to 9.2% from 19.3% a year earlier. Management blamed overly aggressive SKU cuts and acquisition integration issues. This weak result pressures the stock as investors question the pace of recovery.

    The Q2 miss is the central negative event of the period, directly explaining the stock's decline and investor concerns.

  • Analyst Price Target Cuts and Downgrade Needham, UBS, and Roth Capital lowered their price targets on Celsius while keeping Buy ratings, citing slower fundamentals and reduced revenue estimates. Later, Deutsche Bank downgraded the stock, sending shares down nearly 6% in one session. These actions reflect growing caution about the company's near-term growth trajectory.

    Analyst downgrades and target cuts directly influence investor sentiment and can pressure the stock price.

  • Competitive Threats from Fast Food and Beverage Giants Fast food chains like McDonald's and Starbucks are rolling out their own energy drinks, with a Citi survey showing 60% of restaurant energy drink purchases are incremental and 49% replace purchases elsewhere. This trend could siphon sales from canned energy drinks, posing a risk to pure-play sellers like Celsius.

    This emerging competitive dynamic threatens Celsius's market share and long-term growth prospects.

  • Insider Buying Signals Confidence Lead Director Hal Kravitz bought 12,000 shares for $336,000 at $28.00 per share, a premium to the closing price, increasing his stake by 5%. Insider buying is often seen as a bullish signal, suggesting management believes the stock is undervalued after its steep decline.

    Insider purchases can boost investor confidence and indicate that those closest to the company see value.

Latest
▼3▲1

Celsius Q2 Miss and Weak Brand Momentum Drive 2026 Decline

  • Q2 Revenue Miss and Margin Collapse Celsius reported Q2 revenue of $817.9 million, missing estimates by 6.2%, with adjusted EPS of $0.36 versus $0.42 expected. Operating margin fell to 9.2% from 19.3% a year earlier. Management blamed overly aggressive SKU cuts and acquisition integration issues. This weak result pressures the stock as investors question the pace of recovery.

    The Q2 miss is the central negative event of the period, directly explaining the stock's decline and investor concerns.

  • Analyst Price Target Cuts and Downgrade Needham, UBS, and Roth Capital lowered their price targets on Celsius while keeping Buy ratings, citing slower fundamentals and reduced revenue estimates. Later, Deutsche Bank downgraded the stock, sending shares down nearly 6% in one session. These actions reflect growing caution about the company's near-term growth trajectory.

    Analyst downgrades and target cuts directly influence investor sentiment and can pressure the stock price.

  • Competitive Threats from Fast Food and Beverage Giants Fast food chains like McDonald's and Starbucks are rolling out their own energy drinks, with a Citi survey showing 60% of restaurant energy drink purchases are incremental and 49% replace purchases elsewhere. This trend could siphon sales from canned energy drinks, posing a risk to pure-play sellers like Celsius.

    This emerging competitive dynamic threatens Celsius's market share and long-term growth prospects.

  • Insider Buying Signals Confidence Lead Director Hal Kravitz bought 12,000 shares for $336,000 at $28.00 per share, a premium to the closing price, increasing his stake by 5%. Insider buying is often seen as a bullish signal, suggesting management believes the stock is undervalued after its steep decline.

    Insider purchases can boost investor confidence and indicate that those closest to the company see value.

July 2026
▼3▲1

Celsius hit by weak Q2, activist push, but takeover interest emerges

  • Texas AG investigation and securities fraud probe Texas Attorney General is investigating whether Celsius markets high-caffeine drinks to children, and law firm Pomerantz is probing potential securities fraud. This regulatory risk could lead to fines or lawsuits, weighing on the stock.

    New legal/regulatory threat that could hurt sales and reputation.

  • Q2 earnings miss and margin pressure Celsius reported Q2 revenue of $817.9 million, up 11% but 6% below forecasts, and adjusted EBITDA fell 12%. Net income dropped 45%. The namesake brand declined 12% due to promotions and inventory issues, sending shares down over 12%.

    Core financial results missed expectations, directly hitting investor confidence.

  • Activist investor demands CEO removal Russ Savage, founder of Rockstar Energy, built a 4.7% stake and is publicly pushing to fire CEO John Fieldly and other executives. This adds uncertainty about leadership and strategy, pressuring the stock.

    Activist campaign creates governance risk and potential management shake-up.

  • Takeover interest from PepsiCo and private equity Celsius is seen as a takeover target, with PepsiCo the most likely buyer given its 11% stake and distribution deal. The stock's 39% decline this year makes it cheaper, and private equity interest adds a potential bid premium.

    M&A speculation could put a floor under the stock and offer upside.

▼3▲1

Celsius hit by weak Q2, activist push, but takeover interest emerges

  • Texas AG investigation and securities fraud probe Texas Attorney General is investigating whether Celsius markets high-caffeine drinks to children, and law firm Pomerantz is probing potential securities fraud. This regulatory risk could lead to fines or lawsuits, weighing on the stock.

    New legal/regulatory threat that could hurt sales and reputation.

  • Q2 earnings miss and margin pressure Celsius reported Q2 revenue of $817.9 million, up 11% but 6% below forecasts, and adjusted EBITDA fell 12%. Net income dropped 45%. The namesake brand declined 12% due to promotions and inventory issues, sending shares down over 12%.

    Core financial results missed expectations, directly hitting investor confidence.

  • Activist investor demands CEO removal Russ Savage, founder of Rockstar Energy, built a 4.7% stake and is publicly pushing to fire CEO John Fieldly and other executives. This adds uncertainty about leadership and strategy, pressuring the stock.

    Activist campaign creates governance risk and potential management shake-up.

  • Takeover interest from PepsiCo and private equity Celsius is seen as a takeover target, with PepsiCo the most likely buyer given its 11% stake and distribution deal. The stock's 39% decline this year makes it cheaper, and private equity interest adds a potential bid premium.

    M&A speculation could put a floor under the stock and offer upside.

Monster Beverage Corp (MNST)

Q3 2026
▲2▼2

Monster Beverage Q3 2026: Strong Sales, Margin Pressure, Regulatory Risk

  • Record Sales Growth Monster's Q1 sales jumped 27% to $2.35 billion and Q2 sales rose over 20%, driven by new products and international expansion. This strong top-line growth shows robust demand for its beverages.

    It highlights the primary positive force behind Monster's performance in Q3 2026.

  • International Expansion Overseas revenue surged 34.6%, now 46% of total sales, fueled by Coca-Cola's distribution network and rapid growth in China, India, and Brazil. This geographic diversification is a key growth engine.

    It explains a major driver of Monster's growth and future potential.

  • Margin Pressure Operating margins fell to 29.2% on higher freight, fuel, and marketing costs, with management warning of persistent pressure. This profitability squeeze is a significant headwind.

    It identifies a key negative factor affecting Monster's earnings and stock price.

  • Regulatory and Leadership Risks The UK plans to ban high-caffeine energy drink sales to under-16s by April 2027, threatening future sales. Additionally, the Americas CEO departed for Coca-Cola, creating leadership uncertainty.

    It highlights emerging risks that could impact Monster's future performance and investor confidence.

August 2026
▲2▼1

Monster's global growth shines, but margin and leadership risks emerge

  • Q2 sales surge on innovation and global demand Monster's Q2 net sales jumped 21.6% to $2.36 billion, with energy drink case sales up 22%. New products like Ultra, Reign, and Bang drove growth, and July sales were up 14.3%. This strong demand directly boosts revenue and profit, pushing the stock up.

    This is the core positive fundamental driver of the period, showing accelerating sales and innovation.

  • International sales jump 34.6% on Coca-Cola distribution Overseas revenue rose 34.6% to $1.16 billion, now 46% of total sales. China, India, and Brazil grew 62.5%, 84%, and 82%. This expands Monster's reach and profit dollars, though lower margins abroad can dilute overall profitability.

    International expansion is a major growth engine and a key reason for the stock's long-term appeal.

  • Americas CEO Gehring leaves for Coca-Cola Rob Gehring, head of Monster's key Americas division and a potential CEO successor, is leaving for Coca-Cola. Analysts call it 'somewhat negative,' and the stock fell 2.8% on the news. This creates leadership uncertainty in Monster's most important market.

    The unexpected departure of a top executive in the core business is a clear negative catalyst.

  • Regulatory relief in India, but UK ban looms India's court allowed Monster to sell existing 'energy drink' labeled stock, easing a sales halt. However, the UK will ban high-caffeine energy drink sales to under-16s from April 2027. India relief is positive; UK ban is a negative for future sales.

    Regulatory changes directly affect Monster's ability to sell in key markets, with both positive and negative developments.

Latest
▲2▼1

Monster's global growth shines, but margin and leadership risks emerge

  • Q2 sales surge on innovation and global demand Monster's Q2 net sales jumped 21.6% to $2.36 billion, with energy drink case sales up 22%. New products like Ultra, Reign, and Bang drove growth, and July sales were up 14.3%. This strong demand directly boosts revenue and profit, pushing the stock up.

    This is the core positive fundamental driver of the period, showing accelerating sales and innovation.

  • International sales jump 34.6% on Coca-Cola distribution Overseas revenue rose 34.6% to $1.16 billion, now 46% of total sales. China, India, and Brazil grew 62.5%, 84%, and 82%. This expands Monster's reach and profit dollars, though lower margins abroad can dilute overall profitability.

    International expansion is a major growth engine and a key reason for the stock's long-term appeal.

  • Americas CEO Gehring leaves for Coca-Cola Rob Gehring, head of Monster's key Americas division and a potential CEO successor, is leaving for Coca-Cola. Analysts call it 'somewhat negative,' and the stock fell 2.8% on the news. This creates leadership uncertainty in Monster's most important market.

    The unexpected departure of a top executive in the core business is a clear negative catalyst.

  • Regulatory relief in India, but UK ban looms India's court allowed Monster to sell existing 'energy drink' labeled stock, easing a sales halt. However, the UK will ban high-caffeine energy drink sales to under-16s from April 2027. India relief is positive; UK ban is a negative for future sales.

    Regulatory changes directly affect Monster's ability to sell in key markets, with both positive and negative developments.

July 2026
▲2▼2

Monster's sales boom, but costs and a downgrade weigh on the stock

  • Record Q1 sales and product expansion Monster's first-quarter sales jumped 27% to a record $2.35 billion, beating expectations, as global demand and new products like Ultra Punk Punch and FLRT drove growth. This strong performance pushed the stock up 20% after the report.

    This is the first major new event of the period and shows the core growth driver.

  • Deutsche Bank downgrade on limited upside Deutsche Bank downgraded Monster to Hold from Buy, saying the stock's recent outperformance left little room for further gains. The downgrade caused a 1% dip, signaling that analysts see the stock as fairly valued after its run-up.

    This is a new analyst action that directly affects sentiment and valuation.

  • Strong Q2 sales and stock split Monster's second-quarter sales rose 20.2% to $2.54 billion, with international sales surging 34.6%. The company also announced a two-for-one stock split, making shares more affordable and potentially attracting more investors.

    This is a major new earnings report and corporate action that impacts the stock's appeal.

  • Q2 margin decline on higher costs Despite beating revenue estimates, Monster's operating margin fell to 29.2% from 30.9% due to higher freight, fuel, and marketing costs. Management warned these pressures could persist, which overshadowed the sales beat and weighed on the stock.

    This is the key counterweight to the strong sales growth and explains why the stock fell after Q2.

▲2▼2

Monster's sales boom, but costs and a downgrade weigh on the stock

  • Record Q1 sales and product expansion Monster's first-quarter sales jumped 27% to a record $2.35 billion, beating expectations, as global demand and new products like Ultra Punk Punch and FLRT drove growth. This strong performance pushed the stock up 20% after the report.

    This is the first major new event of the period and shows the core growth driver.

  • Deutsche Bank downgrade on limited upside Deutsche Bank downgraded Monster to Hold from Buy, saying the stock's recent outperformance left little room for further gains. The downgrade caused a 1% dip, signaling that analysts see the stock as fairly valued after its run-up.

    This is a new analyst action that directly affects sentiment and valuation.

  • Strong Q2 sales and stock split Monster's second-quarter sales rose 20.2% to $2.54 billion, with international sales surging 34.6%. The company also announced a two-for-one stock split, making shares more affordable and potentially attracting more investors.

    This is a major new earnings report and corporate action that impacts the stock's appeal.

  • Q2 margin decline on higher costs Despite beating revenue estimates, Monster's operating margin fell to 29.2% from 30.9% due to higher freight, fuel, and marketing costs. Management warned these pressures could persist, which overshadowed the sales beat and weighed on the stock.

    This is the key counterweight to the strong sales growth and explains why the stock fell after Q2.